Primary Site >> Liver Cancer
Gene >> USP22
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: [Construction and identification of eukaryotic expression plasmid expressing siRNA targeting USP22 gene]. PMID: 21500546 |
Ref: Knock-down of USP22 by small interfering RNA interference inhibits HepG2 cell proliferation and induces cell cycle arrest. PMID: 23217440 |
Ref: High USP22 expression indicates poor prognosis in hepatocellular carcinoma. PMID: 25909224 Ref: Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma. PMID: 26497847 |
Ref: The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis. PMID: 27920552 |
Ref: LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells. PMID: 28166203 Ref: USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway. PMID: 28417539 Ref: USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4. PMID: 28427243 Ref: USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt. PMID: 28445968 Ref: lncRNA HULC promotes the growth of hepatocellular carcinoma cells via stabilizing COX-2 protein. PMID: 28634076 |
Ref: Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells. PMID: 30224477 |